Nuveen Asset Management, LLC Corcept Therapeutics Inc Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 223,365 shares of CORT stock, worth $10.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

223,365

Previous 219,037 1.98%

Holding current value

$10.3 Million

Previous $5.52 Million 31.54%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$22.21 - $34.48 $96,124 - $149,229	4,328 Added 1.98%	223,365 $7.26 Million
Q1 2024 May 13, 2024	SELL	$21.1 - $27.46 $935,869 - $1.22 Million	-44,354 Reduced 16.84%	219,037 $5.52 Million
Q4 2023 Feb 14, 2024	BUY	$24.82 - $32.88 $124,373 - $164,761	5,011 Added 1.94%	263,391 $8.55 Million
Q3 2023 Nov 14, 2023	SELL	$21.97 - $33.8 $445,244 - $684,990	-20,266 Reduced 7.27%	258,380 $7.04 Million
Q2 2023 Aug 14, 2023	BUY	$21.44 - $25.15 $677,375 - $794,589	31,594 Added 12.79%	278,646 $6.2 Million
Q1 2023 May 15, 2023	SELL	$19.2 - $24.47 $134,515 - $171,436	-7,006 Reduced 2.76%	247,052 $5.35 Million
Q4 2022 Feb 14, 2023	SELL	$19.95 - $29.96 $179,270 - $269,220	-8,986 Reduced 3.42%	254,058 $5.16 Million
Q3 2022 Nov 14, 2022	SELL	$24.7 - $29.12 $4.02 Million - $4.75 Million	-162,954 Reduced 38.25%	263,044 $6.74 Million
Q2 2022 Aug 15, 2022	BUY	$17.33 - $25.3 $1.25 Million - $1.83 Million	72,237 Added 20.42%	425,998 $10.1 Million
Q1 2022 May 16, 2022	BUY	$16.53 - $25.21 $1.08 Million - $1.64 Million	65,122 Added 22.56%	353,761 $8.71 Million
Q4 2021 Feb 14, 2022	SELL	$17.1 - $23.34 $880,992 - $1.2 Million	-51,520 Reduced 15.15%	288,639 $5.58 Million
Q3 2021 Nov 12, 2021	SELL	$19.68 - $22.53 $841,831 - $963,743	-42,776 Reduced 11.17%	340,159 $6.7 Million
Q2 2021 Aug 16, 2021	SELL	$19.97 - $24.43 $1.15 Million - $1.4 Million	-57,467 Reduced 13.05%	382,935 $8.43 Million
Q1 2021 May 17, 2021	BUY	$23.49 - $30.56 $54,355 - $70,715	2,314 Added 0.53%	440,402 $10.5 Million
Q4 2020 Feb 16, 2021	BUY	$16.78 - $27.3 $6,879 - $11,193	410 Added 0.09%	438,088 $11.5 Million
Q3 2020 Nov 16, 2020	SELL	$12.46 - $19.98 $2.62 Million - $4.19 Million	-209,925 Reduced 32.42%	437,678 $7.62 Million
Q2 2020 Aug 14, 2020	BUY	$11.0 - $18.26 $49,148 - $81,585	4,468 Added 0.69%	647,603 $10.9 Million
Q1 2020 May 14, 2020	BUY	$10.11 - $14.04 $1.89 Million - $2.63 Million	187,239 Added 41.07%	643,135 $7.65 Million
Q4 2019 Feb 14, 2020	SELL	$12.06 - $16.96 $750,879 - $1.06 Million	-62,262 Reduced 12.02%	455,896 $5.52 Million
Q3 2019 Nov 14, 2019	SELL	$10.41 - $14.66 $48,094 - $67,729	-4,620 Reduced 0.88%	518,158 $7.32 Million
Q2 2019 Aug 15, 2019	BUY	$9.78 - $12.76 $5.11 Million - $6.67 Million	522,778 New	522,778 $5.83 Million

Others Institutions Holding CORT

# of Institutions

311

Shares Held

88.3M

Call Options Held

1.07M

Put Options Held

973K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $4.95B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Corcept Therapeutics Inc Transaction History